Franklin Templeton has announced the launch of the FTGF Putnam US Research Fund in Singapore and Hong Kong, marking the introduction of Putnam Investments’ strategies in Asia. This initiative aims to broaden investor access to differentiated investment opportunities, focusing on US large-cap equities with a sector-neutral portfolio. The fund is backed by Putnam’s extensive research capabilities, with analysts based in Boston, London, and Singapore.
The FTGF Putnam US Research Fund has been registered as an authorised scheme for retail investors in both Singapore and Hong Kong. Christian Bucaro, Head of Wealth for Asia at Franklin Templeton, highlighted Putnam’s reputation for deep research capabilities and consistent results. He stated, “We are delighted to broaden investor access to Putnam’s compelling investment strategies, starting with the FTGF Putnam US Research Fund, which seeks to achieve smoother relative performance through volatile markets.”
Kate Lakin, Portfolio Manager and Director of Research at Putnam Investments, explained that the fund’s sector-neutral portfolio aims to generate differentiated alpha through stock-specific exposures. “Our tenured team has deep sector expertise focused on driving returns from stock selection,” she noted.
In addition to the FTGF Putnam US Research Fund, Franklin Templeton has also registered the FTGF Franklin Ultra Short Duration Income Fund for retail investors in Singapore. The company plans to expand access to Putnam’s stock-driven equity strategies in Asia, covering sectors such as global healthcare.
Putnam Investments, with roots dating back to 1937, manages $129 billion (£103 billion) in assets and is known for its value, core, and growth strategies across various market caps. As of May 2025, 88% of Putnam’s mutual fund assets are rated 4 or 5 stars by Morningstar.
“`
